<DOC>
	<DOCNO>NCT01385774</DOCNO>
	<brief_summary>The purpose study compare clinical effectiveness cost-effectiveness two treatment strategy Intermittent Claudication ( IC ) due iliac artery obstruction : start SUPERvised Exercise Therapy ( SET ) defer Percutaneous Transluminal Angioplasty ( PTA ) case SET failure , immediate PTA . It hypothesis PTA first line treatment effective SET first line treatment regard maximum walk distance , quality life cost one year .</brief_summary>
	<brief_title>SUPER Study ; SUPERvised Exercise Angioplasty Intermittent Claudication Due Iliac Artery Obstruction .</brief_title>
	<detailed_description>Intermittent claudication ( IC ) manifestation cardiovascular disease , reflect threefold increase risk patient develop serious cardiovascular event . Treatment patient IC aim secondary prevention cardiovascular event control risk factor atherosclerotic disease , improve walk distance subsequently quality life . Supervised Exercise Therapy ( SET ) Percutaneous Transluminal Angioplasty ( PTA ) effectively improve pain free walking distance , optimal choice treatment , specifically patient iliac artery stenosis occlusion unclear . PTA attractive initial therapy since PTA iliac artery immediate effect durable . There lack evidence randomize control trial ( RCT ) define optimal treatment strategy patient IC due iliac artery lesion ; first line treatment SET PTA case failure , immediate iliac artery PTA . Purpose : To define optimal treatment strategy IC due iliac artery obstruction : To start SET deferred PTA case SET failure , immediate PTA . Design : Multicenter randomize control trial . Patients : 400 patient IC due iliac artery stenosis occlusion . Interventions : SET PTA . Outcomes : Primary outcomes quality life ( Qol ) record disease specific VascuQol instrument maximum walk distance standardize treadmill test speed 3.2 km/h 10 % incline 1 year . Secondary outcome pain-free walk distance , generic Qol , functional status , complication , number treatment failures cost . Economic evaluation comprise cost-effectiveness cost-utility analysis societal perspective , cost per patient able walk maximal , respectively cost per Quality Adjusted Life-Year ( QALY ) outcome measure .</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Intermittent Claudication</mesh_term>
	<criteria>1 . Age 18 year old ; 2 . Disabling claudication define surgeon base patient 's history ; 3 . Ankle/Brachial Index ( ABI ) &lt; 0.9 drop ABI &gt; 0.15 exercise test ; 4 . Hemodynamic stenosis common external iliac artery Color Duplex Scanning ( CDS ) ( PSV ratio ≥ 2.5 EDV ≥ 0.6 m/s ) Magnetic Resonance Angiography ( MRA ) Computed Tomography Angiography ( CTA ) ( &gt; 50 % stenosis ) occlusion common external iliac artery CDS ( PSV 0 m/s ) MRA CTA ; 5 . Iliac artery lesion concomitant stenosis superficial femoral artery define stenosis &gt; 50 % CDS ( PSV ratio ≥ 2.5 EDV ≥ 0.6 m/s ) MRA CTA , occlusion CDS ( PSV 0 m/s ) MRA CTA ; 6 . Lesion classify A , B C accord TASC ( TransAtlantic InterSociety Consensus ) classification aortoiliac lesion ; 7 . Patient able walk least 2 minute treadmill 3.2 km/h 10 % incline ; 8 . The Maximum Walking Distance treadmill &lt; 300 meter . 1 . Life expectancy &lt; 3 month ; 2 . Patient unable complete selfreported questionnaire ( insufficiently read speak Dutch language , cognitive disorder , etc ) ; 3 . Patient unable give inform consent ; 4 . A documented contrast allergy ; 5 . Pregnancy ; 6 . Contraindication anticoagulant therapy ; 7 . Duration current complaint &lt; 3 month ; 8 . Occlusion common femoral artery affect side ; 9 . Patient participate another study ; 10 . Heart failure Angina Pectoris NYHA III IV . ( NYHA III : Marked limitation physical activity . Comfortable rest , less ordinary activity cause fatigue , palpitation , dyspnea ; NYHA IV : Unable carry physical activity without discomfort . Symptoms cardiac insufficiency rest . If physical activity undertaken , discomfort increase ) ; 11 . Patient previously receive Supervised Exercise Therapy ( SET ) accord KNGF ( Dutch Society Physiotherapists ) guideline ; 12 . Renal insufficiency ( serum creatinin &gt; 150 micromol/l ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Intermittent Claudication</keyword>
	<keyword>Percutaneous Transluminal Angioplasty</keyword>
	<keyword>Supervised Exercise Therapy</keyword>
	<keyword>Peripheral Arterial Disease</keyword>
</DOC>